Alibaba Group Hldg LTD (BABA) Holder Miracle Mile Advisors Boosted Holding; Omeros (OMER) Holder American Financial Group Has Lowered Its Stake

June 19, 2018 - By Peter Erickson

Omeros Corporation (NASDAQ:OMER) Logo

Miracle Mile Advisors Llc increased its stake in Alibaba Group Hldg Ltd (BABA) by 1579.08% based on its latest 2018Q1 regulatory filing with the SEC. Miracle Mile Advisors Llc bought 20,607 shares as the company’s stock rose 2.58% while stock markets declined. The institutional investor held 21,912 shares of the business services company at the end of 2018Q1, valued at $4.02 million, up from 1,305 at the end of the previous reported quarter. Miracle Mile Advisors Llc who had been investing in Alibaba Group Hldg Ltd for a number of months, seems to be bullish on the $524.12 billion market cap company. The stock decreased 2.20% or $4.59 during the last trading session, reaching $203.98. About 20.25M shares traded or 16.20% up from the average. Alibaba Group Holding Limited (NYSE:BABA) has risen 61.13% since June 19, 2017 and is uptrending. It has outperformed by 48.56% the S&P500. Some Historical BABA News: 21/03/2018 – Alibaba, JD.com to list in China as early as June, sources say; 04/05/2018 – Alibaba Group 4Q Adjusted EBITA Margin for Core Commerce 43%; 18/04/2018 – OATH SAYS K. GURU GOWRAPPAN WILL JOIN COMPANY AS PRESIDENT AND COO; 29/05/2018 – Alibaba and Cainiao Make Strategic Investment in ZTO Express; 04/05/2018 – Alibaba Group 4Q-End Mobile MAUs on China Retail Marketplaces 617M; 03/05/2018 – ♫ Reuters Insider – U.S. Day Ahead: Job growth seen improving along with profit at Alibaba; 10/04/2018 – ADRs End Higher; Alibaba, Telecom Italia Trade Actively; 17/04/2018 – Tech giants remain most crowded trade for third month running – BAML survey; 04/05/2018 – Alibaba’s Bets Better Payoff; 20/04/2018 – ALIBABA BABA.N SAYS ACQUIRES CHINESE CHIP MAKER HANGZHOU C-SKY MICROSYSTEMS

American Financial Group Inc decreased its stake in Omeros Corp (OMER) by 52.41% based on its latest 2018Q1 regulatory filing with the SEC. American Financial Group Inc sold 374,817 shares as the company’s stock rose 78.30% while stock markets declined. The institutional investor held 340,284 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $3.80 million, down from 715,101 at the end of the previous reported quarter. American Financial Group Inc who had been investing in Omeros Corp for a number of months, seems to be less bullish one the $911.28M market cap company. The stock decreased 2.88% or $0.56 during the last trading session, reaching $18.87. About 716,022 shares traded. Omeros Corporation (NASDAQ:OMER) has risen 24.49% since June 19, 2017 and is uptrending. It has outperformed by 11.92% the S&P500. Some Historical OMER News: 11/04/2018 – OMEROS CORP – UNDER CREDIT FACILITY, OMEROS MAY BORROW UP TO AN ADDITIONAL $45.0 MLN ON OR BEFORE MAY 20, 2018; 24/05/2018 – OMEROS CORP – LUPIN IS GRANTED NON-EXCLUSIVE, NON-SUBLICENSABLE WAIVER OF CO’S PEDIATRIC EXCLUSIVITY FOR OMIDRIA UNTIL AT LEAST APRIL 23, 2034; 24/05/2018 – OMEROS SAYS ENTERED INTO SETTLEMENT AGREEMENT AND CONSENT JUDGMENT WITH LUPIN LTD, SUBSIDIARY LUPIN PHARMACEUTICALS – SEC FILING; 11/04/2018 – Omeros Announces Amendment of Credit Facility; 26/04/2018 – Omeros: Discussions Ongoing With FDA, European Regulators for Expedited Approval; 19/04/2018 – OMEROS: ADDED CLINICAL STUDIES SUPPORT OMIDRIA BENEFITS; 19/04/2018 – Additional Clinical Studies Supporting the Benefits of OMIDRIA® Presented at the American Society of Cataract and Refractive; 24/05/2018 – OMEROS – AGREEMENT RESOLVES CO’S PATENT LITIGATION AGAINST LUPIN; 26/04/2018 – OMEROS CORP OMER.O – DISCUSSIONS ONGOING WITH FDA AND EUROPEAN REGULATORS FOR EXPEDITED APPROVAL OF OMS721; 24/05/2018 – OMEROS – LUPIN GRANTED LICENSE TO MAKE, SELL GENERIC VERSION OF OMIDRIA BETWEEN PERMITTED LAUNCH DATE & LATEST EXPIRATION OF CO’S U.S. PATENTS

Miracle Mile Advisors Llc, which manages about $371.73M and $945.41M US Long portfolio, decreased its stake in Wisdomtree Tr (HEDJ) by 437,280 shares to 8,136 shares, valued at $510,000 in 2018Q1, according to the filing. It also reduced its holding in Vanguard Index Fds (VO) by 3,237 shares in the quarter, leaving it with 2,905 shares, and cut its stake in First Tr Exchange Traded Fd (EMLP).

More notable recent Alibaba Group Holding Limited (NYSE:BABA) news were published by: Seekingalpha.com which released: “Alibaba Knows No Boundaries” on June 01, 2018, also Livetradingnews.com with their article: “Alibaba Group Holding Limited (NYSE:BABA) Given News Sentiment Score of 0.35” published on June 18, 2018, Livetradingnews.com published: “Alibaba Group Holding Limited (NYSE:BABA) Logistics Plays Can Strengthen Leadership in Chinese B2C E …” on June 15, 2018. More interesting news about Alibaba Group Holding Limited (NYSE:BABA) were released by: Seekingalpha.com and their article: “Difficult Not To Win With Alibaba” published on June 14, 2018 as well as Livetradingnews.com‘s news article titled: “Alibaba Group Holding Limited (NYSE:BABA) Alibaba Ends Day Higher” with publication date: June 19, 2018.

Among 39 analysts covering Alibaba (NYSE:BABA), 37 have Buy rating, 1 Sell and 1 Hold. Therefore 95% are positive. Alibaba had 183 analyst reports since August 12, 2015 according to SRatingsIntel. The firm earned “Overweight” rating on Thursday, December 8 by Morgan Stanley. Stifel Nicolaus maintained it with “Buy” rating and $88 target in Thursday, September 10 report. SunTrust maintained it with “Buy” rating and $200.0 target in Friday, August 18 report. The stock has “Outperform” rating by Bernstein on Wednesday, January 11. As per Thursday, June 8, the company rating was maintained by Stifel Nicolaus. The company was maintained on Monday, August 21 by Barclays Capital. The firm earned “Overweight” rating on Tuesday, June 28 by Morgan Stanley. RBC Capital Markets maintained it with “Outperform” rating and $95 target in Wednesday, October 28 report. The firm has “Buy” rating by Oppenheimer given on Monday, June 26. The stock of Alibaba Group Holding Limited (NYSE:BABA) has “Buy” rating given on Thursday, November 3 by Jefferies.

More news for Omeros Corporation (NASDAQ:OMER) were recently published by: Seekingalpha.com, which released: “Omeros Corporation: OMS721 In HSCT-TMA And IgAN Plus Omidria Worth $2.5 Billion” on June 05, 2018. Seekingalpha.com‘s article titled: “Is It Time To Close Out The Omeros Corporation Trade?” and published on June 13, 2018 is yet another important article.

Since January 3, 2018, it had 0 insider buys, and 3 insider sales for $1.93 million activity. JACOBSEN MICHAEL A sold $22,899 worth of Omeros Corporation (NASDAQ:OMER) on Wednesday, January 3.

Investors sentiment decreased to 1.04 in Q1 2018. Its down 0.26, from 1.3 in 2017Q4. It dropped, as 20 investors sold OMER shares while 26 reduced holdings. 15 funds opened positions while 33 raised stakes. 20.39 million shares or 7.05% less from 21.94 million shares in 2017Q4 were reported. Vanguard Group holds 2.32 million shares or 0% of its portfolio. D E Shaw And Inc invested 0% of its portfolio in Omeros Corporation (NASDAQ:OMER). Da Davidson & stated it has 0.02% of its portfolio in Omeros Corporation (NASDAQ:OMER). Boothbay Fund Management Lc owns 69,600 shares. Voya Mgmt Limited Co holds 0% or 20,538 shares. Tiaa Cref Investment Mgmt Ltd Liability Com has invested 0% of its portfolio in Omeros Corporation (NASDAQ:OMER). Bnp Paribas Arbitrage Sa stated it has 0% of its portfolio in Omeros Corporation (NASDAQ:OMER). Amer Inc reported 0% in Omeros Corporation (NASDAQ:OMER). Moreover, Tudor Et Al has 0.01% invested in Omeros Corporation (NASDAQ:OMER) for 36,225 shares. Ameritas Prtn holds 0% in Omeros Corporation (NASDAQ:OMER) or 3,655 shares. Moreover, Proshare Limited Liability Company has 0% invested in Omeros Corporation (NASDAQ:OMER). Cambridge Rech Inc holds 14,795 shares. 57,306 are held by Aqr Capital Mngmt Lc. Blackrock holds 3.97 million shares or 0% of its portfolio. 62,467 are held by First Tru Advsr L P.

Analysts await Omeros Corporation (NASDAQ:OMER) to report earnings on August, 14. They expect $-0.62 EPS, down 169.57% or $0.39 from last year’s $-0.23 per share. After $-0.53 actual EPS reported by Omeros Corporation for the previous quarter, Wall Street now forecasts 16.98% negative EPS growth.

Omeros Corporation (NASDAQ:OMER) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>